Boosting Oxygen Reduction Reaction in Alkaline Media via Fe-N<sub>x</sub>-Enriched Carbon Electrocatalysts Derived from Waste Pod Shells. [PDF]
Yan R, Wang K, Zhang T, Xu H.
europepmc +1 more source
Nonprecious bifunctional electrocatalysts for oxygen electrode reactions. [PDF]
Bhuyan SP +4 more
europepmc +1 more source
Immunotherapy in Advanced Epithelial Ovarian Cancer: Successes and Frustrations. [PDF]
Marshall LA +3 more
europepmc +1 more source
Correction: Mamat @ Yusof et al. Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 15233. [PDF]
Mamat Yusof MN +3 more
europepmc +1 more source
Dynamic Self-Optimization of PtNi Nanocatalysts Through the Concurrent Evolution of Active Sites and Interfacial Environment During Reaction. [PDF]
Wang W +5 more
europepmc +1 more source
Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Anti-Angiogenic Tyrosine Kinase Inhibitors for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Systematic Review and Single-Arm Meta-Analysis. [PDF]
Hu R, Li T, Luo Z, Chen H, Qu S.
europepmc +1 more source
Sequential therapy with anlotinib and radioiodine for distant metastatic differentiated thyroid cancer: a phase II clinical trial. [PDF]
Song H +6 more
europepmc +1 more source
Myeloid-Adaptive Response to Atezolizumab (MARTA): A Two-Gene CXCL13-CXCL8 Transcriptomic Biomarker Across Renal Cell and Urothelial Carcinoma. [PDF]
Uccello M.
europepmc +1 more source
Protocol-optimized wide-field optical redox imaging for T cell activation and its potential for immunological research. [PDF]
Wen YY, Nandi A, Xu HN, Huang A, Li LZ.
europepmc +1 more source
Next-Generation CAR-T Cell Therapy: From Modular Design to Clinical Expansion. [PDF]
Bai Y +5 more
europepmc +1 more source

